Alnylam Pharmaceuticals (ALNY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.007% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q3 2024 | |||||
| ≡ | Dodge & Cox | Reduce 1.24% | 29,100 | 0.01 | |
| Q4 2023 | |||||
| ≡ | Dodge & Cox | Reduce 2.12% | 50,800 | 0.01 | |
| Q2 2023 | |||||
| ≡ | Dodge & Cox | Reduce 1.44% | 34,800 | 0.01 | |
| Q1 2023 | |||||
| ≡ | Dodge & Cox | Reduce 18.29% | 541,777 | 0.12 | |
| Q4 2022 | |||||
| ≡ | Dodge & Cox | Reduce 2.68% | 81,600 | 0.02 | |
| Q3 2022 | |||||
| ≡ | Dodge & Cox | Reduce 1.78% | 55,000 | 0.02 | |
| Q2 2022 | |||||
| ≡ | Dodge & Cox | Reduce 4.64% | 150,800 | 0.03 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 3,983 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 98.64% | 288,700 | 0.72 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 63.24% | 503,551 | 0.81 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 19.12% | 188,268 | 0.25 | |
| ≡ | Dodge & Cox | Reduce 8.59% | 227,669 | 0.04 | |
| Q4 2020 | |||||
| ≡ | Dodge & Cox | Reduce 0.16% | 4,300 | 0.00 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 13.12% | 146,147 | 0.40 | |
| ≡ | Dodge & Cox | Reduce 2.99% | 81,800 | 0.02 | |
| Q2 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 16.88% | 226,097 | 0.70 | |
| ≡ | Dodge & Cox | Reduce 11.34% | 350,000 | 0.09 | |
| ≡ | First Eagle Investment Management | Sell 100.00% | 26,500 | 0.01 | |
| Q1 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 40.74% | 921,192 | 2.12 | |
| ≡ | Dodge & Cox | Reduce 3.52% | 112,500 | 0.02 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 29.85% | 961,916 | 1.61 | |
| Q3 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 23.92% | 1,013,203 | 1.20 | |
| Q1 2018 | |||||
| ≡ | Dodge & Cox | Reduce 42.48% | 2,077,874 | 0.36 | |
| Q4 2017 | |||||
| ≡ | Dodge & Cox | Reduce 11.07% | 609,000 | 0.11 | |
| Q2 2013 | |||||
| ≡ | Thomas Russo - Gardner Russo & Quinn | Sell 100.00% | 75 | 0.00 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.